Discover 3,059 paid clinical trials in Pennsylvania. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Pennsylvania provides numerous options to healthy volunteers looking to take part in paid research studies, as well as participants looking for condition-specific trials. Research hubs in Philadelphia, Pittsburgh, and Allentown are actively recruiting participants, giving access to groundbreaking treatments and quality healthcare.
Filter
1
Filter results
Results: 3,059
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
for
Multiple Sclerosis Spasticity
Location: Foxborough MA, Levis, Montreal, Philadelphia PA, Ottawa,
Sponsor: Celgene
Sex: All
Age: 18 - 70
Code: NCT06782490
Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
for
Major Depressive Disorder (MDD),
Location: Russells Mills MA, Boston MA, Cromwell CT,
Sponsor: Seaport Therapeutics
Sex: All
Age: 18 - 65
Code: NCT07065240
Phase 2, Recruiting
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
for
Aortic Regurgitation, Aortic Valve Insufficiency,
Location: Boston MA, New Haven CT, New York NY, New Brunswick NJ,
Sponsor: JenaValve Technology, Inc.
Sex: All
Age: 0+
Code: NCT06608823
Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for
B Acute Lymphoblastic Leukemia
Location: Halifax, Scarborough ME, Boston MA, Providence RI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 46
Code: NCT06124157
Phase 2, Recruiting
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
for
Tibial Fractures, Pain
Location: Cambridge MA, Baltimore MD, Falls Church VA,
Sponsor: Major Extremity Trauma Research Consortium
Sex: All
Age: 18 - 70+
Code: NCT07006675
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Boston MA, New York NY, Philadelphia PA, Columbus OH,
Sponsor: Regeneron Pharmaceuticals
Sex: Female
Age: 18+
Code: NCT04590326
Phase 1, Phase 2, Recruiting
Improving Prosthetic Arms for Amputee: A Better Fit and More Functionality
for
Amputation, Surgical
Location: Pittsburgh PA
Sponsor: VA Office of Research and Development
Sex: All
Age: 0+
Code: NCT05990062
Recruiting
A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
for
Fabry Disease
Location: Fairfax VA, Pittsburgh PA, Charlotte NC, Atlanta GA,
Sponsor: Amicus Therapeutics
Sex: All
Age: 2 - 11
Code: NCT06904261
Phase 3, Recruiting
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
for
Agitation, Alzheimer Disease
Location: Foxborough MA, Manhasset NY, Toms River NJ,
Sponsor: Celgene
Sex: All
Age: 55 - 70+
Code: NCT06808984
Phase 2, Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
for
Pancreatic Neuroendocrine Tumor (pNET),
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT06943755
Phase 2, Phase 3, Recruiting
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
for
Acute Ischemic Stroke, Cerebral Stroke
Location: Paramus NJ, Hershey PA, Chapel Hill NC, Greensboro NC,
Sponsor: Pharmazz, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05691244
Phase 3, Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
for
Recurrent Langerhans Cell Histiocytosis,
Location: Halifax, Hartford CT, New Haven CT, Quebec, Sherbrooke,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 22
Code: NCT05828069
Phase 2, Recruiting
Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis
for
Low-grade Upper Tract Urothelial Carcinoma
Location: New York NY, Philadelphia PA, Jacksonville FL,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06668493
Phase 1, Phase 2, Recruiting
Transdiagnostic Sleep and Circadian Intervention + Bright Light in Adolescents With Elevated Depression (TranS-C+BL)
for
Sleep Disturbance, Sleep, Depression, Suicide
Location: Philadelphia PA, Pittsburgh PA
Sponsor: University of Pittsburgh
Sex: All
Age: 12 - 18
Code: NCT06963463
Recruiting
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
for
Heart Failure
Location: Quebec, Winchester, Ottawa, Camp Hill PA,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 40 - 70+
Code: NCT06979362
Phase 2, Recruiting
POCUS-Guided Diuresis for Decompensated Heart Failure
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
for
Renal Cell Carcinoma
Location: Mineola NY, New York NY, Durham NC, Pittsburgh PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18 - 70+
Code: NCT07049926
Phase 1, Phase 2, Recruiting
Effectiveness of Brief Intervention in Primary Care for Diverse Young People (Chat)
for
Adolescent Drinking, Cannabis Use
Location: Pittsburgh PA, Commerce CA, North Hollywood CA
Sponsor: RAND
Sex: All
Age: 12 - 19
Code: NCT06699251
Recruiting
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
for
Pulmonary Disease, Chronic Obstructive
Location: Bangor ME, Fall River MA, Mount Kisco NY,
Sponsor: GlaxoSmithKline
Sex: All
Age: 40 - 70+
Code: NCT06961214
Phase 3, Recruiting
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
for
Endometrial Cancer
Location: St. John's, Scarborough ME, Boston MA, Providence RI,